Our long range objective is to understand molecular mechanisms involved in the pathophysiology of hypertension and hypertrophy. The Renin- angiotensin system plays an important role in the development of these diseases through the action of angiotensin-II, which is one of the most potent vasoactive substance known. Angiotensin-II is synthesized from its precursor molecule, angiotensinogen, by the combined action of renin and angiotensin converting enzyme. Recent studies have shown the presence of an independent renin-angiotensin system in vascular walls. Since angiotensin-II increases the growth of vascular smooth muscle cells (VSMC) and aberrant growth of VSMC is a fundamental pathogenetic feature of hypertension and atherosclerosis, an increased synthesis of angiotensinogen and its conversion into angiotensin_II in vascular walls may have an important role in the development of hypertension and hypertrophy. Since angiotensinogen is the only precursor of angiotensin- II, it is crucial to understand various factors involved in the regulation of angiotensinogen gene expression in VSMC. In order to understand these regulatory factors, we have synthesized an expression plasmid pRA688CAT by attaching 688 bp. 5-flanking region of the rat angiotensinogen gene pRA688CAT has shown that it expresses the CAT gene in primary cultures of VSMC isolated from rat thoracic aorta. Our DNase-I footprint analysis and gel mobility shift assay have also shown that VSMC nuclear extract binds to specific nucleotide sequences present in the promoter of rat angiotensinogen gene. We have also shown that serum, insulin, angiotensin-II transforming growth factor-beta, and dexamethasone modulate the CAT gene expression on transient transfection of pRA688CAT in Hep G2 cells. We now propose to: (a) identify cis-acting DNA elements and transcription factors that are involved in the regulation of tissue specific expression of this gene in VSMC and (b) to compare the expression of angiotensinogen gene in VSMC of normotensive WKY and Spontaneously hypertensive rat, SHR. Theses studies will help us understand the molecular mechanisms involved in hypertension and hypertrophy in other experimental animal models and in humans.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL049884-03
Application #
2225926
Study Section
Medical Biochemistry Study Section (MEDB)
Project Start
1993-12-01
Project End
1997-11-30
Budget Start
1994-12-01
Budget End
1995-11-30
Support Year
3
Fiscal Year
1995
Total Cost
Indirect Cost
Name
New York Medical College
Department
Pathology
Type
Schools of Medicine
DUNS #
City
Valhalla
State
NY
Country
United States
Zip Code
10595
Jain, Sudhir; Li, Yanna; Patil, Sai et al. (2007) HNF-1alpha plays an important role in IL-6-induced expression of the human angiotensinogen gene. Am J Physiol Cell Physiol 293:C401-10
Velez, Digna R; Guruju, Mallikarjunrao; Vinukonda, Govindaiah et al. (2006) Angiotensinogen promoter sequence variants in essential hypertension. Am J Hypertens 19:1278-85
Jain, Sudhir; Shah, Mehul; Li, Yanna et al. (2006) Upregulation of human angiotensinogen (AGT) gene transcription by interferon-gamma: involvement of the STAT1-binding motif in the AGT promoter. Biochim Biophys Acta 1759:340-7
Li, Yanna; Jain, Sudhir; Patil, Sai et al. (2006) A haplotype of angiotensinogen gene that is associated with essential hypertension increases its promoter activity in adipocytes. Vascul Pharmacol 44:29-33
Tang, Xiangna; Guruju, Mallikarjunarao; Rajendran, Geetha P et al. (2006) Role of C825T polymorphism of GNbeta3 gene in preeclampsia. Hypertens Pregnancy 25:93-101
Jain, Sudhir; Li, Yanna; Patil, Sai et al. (2005) A single-nucleotide polymorphism in human angiotensinogen gene is associated with essential hypertension and affects glucocorticoid induced promoter activity. J Mol Med 83:121-31
Jain, Sudhir; Li, Yanna; Kumar, Ashok et al. (2005) Transcriptional signaling from membrane raft-associated glucocorticoid receptor. Biochem Biophys Res Commun 336:3-8
Kumar, Ashok; Li, Yanna; Patil, Sai et al. (2005) A haplotype of the angiotensinogen gene is associated with hypertension in african americans. Clin Exp Pharmacol Physiol 32:495-502
Jain, Sudhir; Tang, Xiangna; Narayanan, Chittampalli S et al. (2002) Angiotensinogen gene polymorphism at -217 affects basal promoter activity and is associated with hypertension in African-Americans. J Biol Chem 277:36889-96
Narayanan, C S; Cui, Y; Kumar, S et al. (2000) cAMP increases the expression of human angiotensinogen gene through a combination of cyclic AMP responsive element binding protein and a liver specific transcription factor. Mol Cell Biochem 212:81-90

Showing the most recent 10 out of 14 publications